Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The effect of exenatide compared to lantus insulin on vascular function before and after a meal tolerance test in patients with type 2 diabetes

Next Previous
Trial Profile

The effect of exenatide compared to lantus insulin on vascular function before and after a meal tolerance test in patients with type 2 diabetes

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Exenatide (Primary) ; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics

Most Recent Events

  • 01 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 02 Oct 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD).
  • 02 Oct 2009 Results from this study were published as an abstract in the proceedings of the 45th Annual Meeting of the European Association for the Study of Diabetes, 29 Sep 2009.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top